Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Argenx Se ADR
(NQ:
ARGX
)
617.49
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,290
Open
617.49
Bid (Size)
620.60 (1)
Ask (Size)
622.20 (1)
Prev. Close
617.49
Today's Range
617.49 - 617.49
52wk Range
327.73 - 622.32
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
argenx to Present at Upcoming Investor Conferences
November 26, 2024
From
argenx SE
Via
GlobeNewswire
argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies
November 20, 2024
From
argenx SE
Via
GlobeNewswire
Performance
YTD
+62.07%
+62.07%
1 Month
+4.90%
+4.90%
3 Month
+20.08%
+20.08%
6 Month
+63.39%
+63.39%
1 Year
+34.90%
+34.90%
More News
Read More
(ARGX) - Analyzing argenx's Short Interest
November 14, 2024
Via
Benzinga
This Bristol-Myers Squibb Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
November 12, 2024
Via
Benzinga
Zai Lab and argenx Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in China
November 11, 2024
From
Zai Lab Limited
Via
Business Wire
Peering Into argenx's Recent Short Interest
November 06, 2024
Via
Benzinga
argenx and Zai Lab Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy in China
November 11, 2024
From
argenx SE
Via
GlobeNewswire
This eBay Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
November 05, 2024
Via
Benzinga
argenx to Participate at Upcoming Investor Conferences
November 05, 2024
From
argenx SE
Via
GlobeNewswire
Argenx Q3 Revenue, EPS Beats Excite Bullish Biotech Analysts: 'Most Enviable I&I Pipeline In Entire Industry'
November 01, 2024
Via
Benzinga
This Atlassian Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
November 01, 2024
Via
Benzinga
The Latest Analyst Ratings For argenx
October 17, 2024
Via
Benzinga
Peeling Back The Layers: Exploring argenx Through Analyst Insights
September 26, 2024
Via
Benzinga
What 25 Analyst Ratings Have To Say About argenx
August 23, 2024
Via
Benzinga
This Huntington Ingalls Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
November 01, 2024
Via
Benzinga
argenx Reports Third Quarter 2024 Financial Results and Provides Business Update
October 31, 2024
From
argenx SE
Via
GlobeNewswire
argenx to Report Third Quarter 2024 Financial Results and Business Update on October 31, 2024
October 24, 2024
From
argenx SE
Via
GlobeNewswire
argenx Highlights Data Showing Patient Impact Across Multiple Immunology Programs at 2024 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting and Myasthenia Gravis Foundation of America Scientific Sessions
October 15, 2024
From
argenx SE
Via
GlobeNewswire
Biotech Stocks : Are You A Trader Or A Longer Term Investor?
October 01, 2024
Via
Talk Markets
Argenx Stock Surges As Amgen Struggles To Take On 'The King' In Autoimmune Diseases
September 25, 2024
Via
Investor's Business Daily
Snowflake, Hawaiian Electric Industries And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
September 24, 2024
Via
Benzinga
argenx Announces Publication in The Lancet Neurology of Pivotal ADHERE Study Data in Chronic Inflammatory Demyelinating Polyneuropathy
September 19, 2024
From
argenx SE
Via
GlobeNewswire
Johnson & Johnson Seeks FDA Approval For Muscle Weakness Drug And Gears Up Showdown With Argenx and UCB
August 29, 2024
Via
Benzinga
Exposures
Product Safety
argenx to Present at Upcoming Investor Conferences
August 28, 2024
From
argenx SE
Via
GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
August 12, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.